Efalizumab (Anti-Integrin aL / ITGAL / CD11a)

Ask supplier a question | View on supplier's website

Efalizumab (Anti-Integrin aL / ITGAL / CD11a) is a humanized IgG1 monoclonal antibody directed against CD11a, the alpha subunit of human leukocyte-function-associated antigen type 1 (LFA-1), with immunosuppressant activity. MW: 145.5 kD.

Supplier	Selleck Chemicals
Product #	A2421
Sku #	A2421-1mg
Pricing	1mg, $370.00

Feedback